Antitumor Activity of Metal(II) Chelates of 2,2′-Bipyridyl-6-Carbothioamide: in Vitro Study

  • P. Franchetti
  • E. Nasini
  • S. Vittori
  • E. Lepri
  • G. Nocentini
  • A. Barzi
Part of the Developments in Oncology book series (DION, volume 54)

Abstract

Our previous studies directed to the investigation of compounds containing the N*-N*-S* tri dentate ligand system as antitumor agents indicated the antileukemic activity of 2,2′-bipyridyl-6-carbothioa-mide (1) (bpyta).

Keywords

Toxicity DMSO Platinum Leukemia Interferon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Antonini, I., Claudi, F., Cristalli, G., Franchetti, P., Grifantini, M. and Martelli, S. J. Med. Chem. 24: 1181–1184, 1981.PubMedCrossRefGoogle Scholar
  2. 2.
    Petering, D.H., Antholine, W.E. and Sarayan, L.A. In: Anticancer and Interferon Agents (Eds. R.M. Ottonbrite and G.B. Butler), Marcel Dekker Inc., New York, 1984, pp 203–246.Google Scholar
  3. 3.
    Antholine, W.E., Knight, J.M. and Petering, D.H. J. Med. Chem. 19: 339–341, 1976.CrossRefGoogle Scholar
  4. 4.
    Saryan, L.A., Ankel, E., Krishnamurti, C. and Petering, D.H. J. Med. Chem. 22: 1218–1221, 1979.CrossRefGoogle Scholar
  5. 5.
    Kessel, D. and Stanley McElhinney, R. Mol. Pharmacol. 11: 298–309, 1975.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1988

Authors and Affiliations

  • P. Franchetti
  • E. Nasini
  • S. Vittori
  • E. Lepri
  • G. Nocentini
  • A. Barzi

There are no affiliations available

Personalised recommendations